Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 00:00 | 20 May | 557.85 |
34.95 (6.68%) |
OPEN
524.50 |
HIGH
559.80 |
LOW
524.05 |
NSE 00:00 | 20 May | 557.95 |
35.10 (6.71%) |
OPEN
523.00 |
HIGH
559.65 |
LOW
523.00 |
OPEN | 524.50 |
PREVIOUS CLOSE | 522.90 |
VOLUME | 270164 |
52-Week high | 1043.00 |
52-Week low | 521.00 |
P/E | 21.43 |
Mkt Cap.(Rs cr) | 32,684 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 8399.97 | 11709.65 | 9646.16 | 8977.31 | 7948.43 |
Other Income | 257.62 | 322.44 | 97.40 | 92.07 | 74.29 |
Total Income | 8657.59 | 12032.09 | 9743.56 | 9069.38 | 8022.72 |
Total Expenditure | 7433.54 | 8565.86 | 7809.00 | 7323.46 | 5756.30 |
Operating Profit | 1224.05 | 3466.23 | 1934.56 | 1745.92 | 2266.42 |
Interest | 12.03 | 22.75 | 78.12 | 96.08 | 35.48 |
Gross Profit | 1212.02 | 3443.48 | 1856.44 | 1649.84 | 2230.94 |
Depreciation | 314.04 | 363.92 | 351.63 | 303.70 | 263.28 |
PBT | 897.98 | 3079.56 | 1504.81 | 1346.14 | 1967.66 |
Tax | 354.29 | 834.36 | 309.69 | 238.05 | 463.18 |
Net Profit/(Loss) | 652.55 | 2240.33 | 1147.70 | 1069.58 | 1504.48 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 652.55 | 2240.33 | 1147.70 | 1069.58 | 1504.48 |
Equity Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 11.14 | 38.51 | 19.59 | 18.25 | 25.68 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices